Drug therapy of osteoporosis – what you should know about it! Osteoporosis (bone loss) is defined by a low bone mass resulting in an increased bone fragility. In Germany, 26% of the population over the age of 50 are currently suffering (= 7.8 million people) on osteoporosis. Bone fragility is the result of a reduced bone strength. The strength of a bone is the bone mass, the material properties and the architecture which determines placement and networking with each other, the bone Trabeculae. For a good mineralization of bones required above all a sufficient supply of calcium, with the absorption of calcium from the intestines and the incorporation of calcium into the bone material is controlled by vitamin D.
This primary care or basic therapy with calcium and vitamin D is guaranteed, the specific drug therapy is added. Osteoporosis drugs attach to the above changes of bone in osteoporosis. Ideal osteoporosis medicines to increase the bone mass, the Join the bone Trabeculae improve and improve the bone material. These are demands that can only partially meet today’s drugs. That’s why it makes sense to use some drugs in combination or in chronological order.
The new brochure of the Board of Trustees bone health e.V. figures are for the various drug groups each to the represented its chemical properties and mechanisms of action, on pharmacokinetics (absorption, storage and elimination), the clinical effect and possible side effects and contra-indications. The Osteoporosis drug therapy brochure what you should know about it! Can against invoice (6.45 euros incl. 1.45 Euro shipping costs) be requested of the Board of Trustees of bone health e.V., Leipziger Strasse 6, 74889 Sinsheim, Tel. 07261/9217-0 (Mon.-Fri. 8: 30 am 12:30) or by email at. The Board of Trustees of bone health e.V. is the oldest national non-profit, the bone health and the Clinical picture takes care of osteoporosis. Since its inception in 1986 that engaged Trustees bone health e.V. to the prevention, treatment and rehabilitation far beyond the osteoporosis for all bone health problems. For 25 years we are a focal point for stakeholders and interested parties and take care of a heart for patients under the motto”that current scientific and medical knowledge in patient-friendly language in flyers, brochures and magazine MobilesLEBEN to introduce a wide audience.